CD44 and head and neck squamous cell carcinoma: Although head and neck squamous cell carcinoma (HNSCC) has a good outcome with surgical intervention, a stem-like chemoresistant cell population that is able to drive relapse has also been identified in HNSCC using CSC cell surface markers such as CD44 [204].